Intuitive Surgical Inc (ISRG) FinancialsISRGIntuitive Surgical Inc

Intuitive Surgical, Inc. (ISRG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Instruments and accessories, accounting for 60.9% of total sales, equivalent to $1.69B. Other significant revenue streams include Systems and Services. Understanding this composition is critical for investors evaluating how ISRG navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Intuitive Surgical, Inc. maintains a gross margin of 67.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 34.32%, while the net margin is 28.46%. These profitability ratios, combined with a Return on Equity (ROE) of 17.43%, provide a clear picture of how effectively ISRG converts its operational activities into shareholder value.

In the context of the broader market, ISRG competes directly with industry leaders such as DHR and ABT. With a market capitalization of $142.99B, it holds a significant position in the sector. When comparing efficiency, ISRG's gross margin of 67.78% stands against DHR's 57.64% and ABT's 52.49%. Such benchmarking helps identify whether Intuitive Surgical, Inc. is trading at a premium or discount relative to its financial performance.

Intuitive Surgical reported approximately $10.1 billion in revenue for FY 2025, with a net income of around $2.9 billion and a net margin of 28%. The company has shown consistent revenue growth, with Q2 2026 revenue of $2.89 billion, up from $2.77 billion in Q1 2026.